Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency in targeted therapies. Also employed in research settings to explore structure-activity relationships in drug design due to the presence of trifluoromethyl and chloroaryl groups, which influence metabolic stability and lipophilicity.